Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

NCT03605251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: TAS5315 low dose
DRUG: TAS5315 high dose
DRUG: Placebos

Sponsor

Taiho Pharmaceutical Co., Ltd.